Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
NAVB > SEC Filings for NAVB > Form 8-K on 2-Jan-2014All Recent SEC Filings

Show all filings for NAVIDEA BIOPHARMACEUTICALS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for NAVIDEA BIOPHARMACEUTICALS, INC.


2-Jan-2014

Other Events


Item 8.01. Other Events.

Senior Executive Salary Reductions

On December 19, 2013, the Company's Compensation, Nominating and Governance Committee recommended reductions in the 2014 base salaries for three of the Company's senior executives, Mark. Pykett, Thom Tulip, and. Brent Larson. Each senior executive agreed to the recommended reduction and delivered to the Company a signed amendment to his respective written employment agreement, causing a salary reduction of 8.9% for Dr. Pykett, 7.5% for Dr. Tulip, and 7.0% for Mr. Larson. Effective January 1, 2014, Dr. Pykett's, Dr. Tulip's and Mr. Larson's annual salaries were revised to $399,000, $314,000 and $260,000, respectively.

  Add NAVB to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for NAVB - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.